Literature DB >> 14636204

IgG antibody reactivity to Borrelia burgdorferi sensu stricto antigens in patients with morphea in Colombia.

Ricardo Palacios1, Antonio Torres, Rodolfo Trujillo.   

Abstract

BACKGROUND: Morphea and lichen sclerosus et atrophicus (LSA) are sclerotic skin lesions of unknown etiology involving connective tissue. The hypothesis of a borrelial origin of morphea and LSA is currently controversial.
METHODS: Immunoglobulin G (IgG) immunoblot serologies against Borrelia burgdorferi in patients with morphea and LSA were analyzed and compared with those from healthy donors and patients with syphilis to determine the association with a probable borrelial agent in Colombia.
RESULTS: No significant differences in the number of reactive antigenic bands were found between morphea/LSA patients and syphilis patients or healthy donors. The presence of at least one of the following bands, p28, p39, or p45, was the criterion most able to distinguish morphea/LSA, yielding a specificity of 95% and a sensitivity of 28.6%. Using this criterion as evidence of putative exposure to a causative borrelial agent, sclerotic skin lesions had an odds ratio of 7.60 (95% confidence interval, 1.47-39.23).
CONCLUSIONS: These results could be explained by cross-reactivity; however, the partial shared reactivity of sera from patients with syphilis and morphea/LSA does not rule out the possibility that a new spirochetal agent, unrelated to B. burgdorferi or Treponemas, may be the causative agent of morphea/LSA in Colombia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14636204     DOI: 10.1046/j.1365-4362.2003.01901.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  1 in total

1.  Localized scleroderma associated with chronic hepatitis C.

Authors:  Felipe Ladeira de Oliveira; Luisa Kelmer Côrtes de Barros Silveira; Maria Lourdes Candela Rambaldi; Fabio Cuiabano Barbosa
Journal:  Case Rep Dermatol Med       Date:  2012-11-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.